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LETTERS
Fatal 
Vibrio vulniﬁ  cus 
Infection Associated 
with Eating 
Raw Oysters, 
New Caledonia
To the Editor: The bacterium Vi-
brio vulniﬁ  cus is a marine ﬂ  ora sap-
rophyte that can cause necrotic skin 
infection and septicemia in humans 
who eat shellﬁ  sh. Symptoms of sep-
ticemia (mortality rate >50%) have 
been described mostly in Florida and 
Japan among persons who ate raw 
ﬁ  lter-feeding shellﬁ  sh when seawater 
temperatures are >20°C (1).
V. vulniﬁ  cus–related septicemia 
introduced through the digestive sys-
tem appears within 7 days after inges-
tion (2). Clinical signs and symptoms 
include fever, collapse, and metastatic 
necrotic skin lesions. We report 3 pa-
tients from New Caledonia who died 
after  V. vulniﬁ  cus infection, which 
they probably acquired by eating con-
taminated oysters. These patients were 
hospitalized during February–May 
2008 at Noumea Hospital (Noumea, 
New Caledonia).
Patient 1 was a 51-year-old man 
with fever, muscle pains, bleeding 
gums, and a history of alcohol abuse; 
within 48 hours after symptom onset, 
he died of septic shock, with diffuse 
ecchymoses and purpura. Patient 2 
was a 67-year-old woman with no 
known concurrent conditions who was 
admitted to the hospital with chills, 
diarrhea, and vomiting; septic shock 
developed, with painful erythematous 
plaques on the lower limbs becoming 
foamy, conﬂ  uent, and necrotic. Patient 
3 was a 74-year-old woman with un-
treated lupus who was hospitalized 
with lower-limb edema, hypotension, 
hypothermia, and erythematous skin 
lesions. All 3 patients received cepha-
losporins but died of multiple organ 
failure within 12 hours after hospital 
admission.
Peripheral blood aerobic–anaer-
obic samples were taken from all pa-
tients, stored in BacT/Alert FA vials 
(bioMérieux, Marcy-l’Etoile, France), 
and incubated in the BacT/Alert 3D 
system (bioMérieux). Curved mobile 
gram-negative bacilli were isolated 
from blood samples cultured on con-
ventional media without additional salt 
within 24 h after incubation at 37°C 
in a 5% CO2-enriched atmosphere. V. 
vulniﬁ  cus was identiﬁ  ed through the 
Vitek2 system (bioMérieux) and con-
ﬁ  rmed by using the Api 20E system 
(bioMérieux).
Strains were sent to the Centre 
National de Reference des Vibrions 
et du Choléra, (Institut Pasteur, Paris, 
France), which by PCR conﬁ  rmed the 
gene encoding virulence-associated 
hemolysin, a species-speciﬁ  c marker 
(3). Molecular typing by pulsed-ﬁ  eld 
gel electrophoresis was performed 
to assess possible clonality of the 
strains.
Several studies have shown the 
genomic diversity among environmen-
tal and clinical V. vulniﬁ  cus isolates. 
The use of genotyping methods has 
identiﬁ  ed >100 V. vulniﬁ  cus strains in 
a single oyster (4) and notable hetero-
geneity among clinical isolates from 
multiple patients, even if a unique 
pathogenic strain causes the infection 
in each patient. Thus, V. vulniﬁ  cus in-
fections within a large population at 
risk may result from rare events con-
trolled more by the host than by the 
bacterial strain (5).
Pulsed-ﬁ   eld gel electrophoresis 
genotype analysis enabled us to divide 
the strains into 2 groups. One group 
included the isolate from patient 1, 
and the other group included isolates 
from patients 2 and 3, which despite 
having slightly different NotI and Sﬁ  I 
patterns reﬂ  ecting genetic rearrange-
ment, clearly belonged to a single 
clone. Isolation of strains with such 
a high degree of homogeneity is not 
common, raising the question of the 
existence of V. vulniﬁ  cus clones that 
are particularly virulent or adapted to 
humans. Currently, however, reliable 
markers for determining V. vulniﬁ  cus 
virulence do not exist. Thus, no geno-
typing system is likely to be useful for 
rapidly identifying strains that affect 
public health (6). V. vulniﬁ  cus–related 
analysis requires the assumption that 
all strains are virulent. 
Epidemiologic information col-
lected from patients’ families indicat-
ed recent consumption of raw oysters. 
Two of the 3 cases occurred within a 
short time frame and were associated 
with eating local oysters harvested on 
the west coast of New Caledonia.
The literature mentions few cases 
of V. vulniﬁ  cus infection in the South 
Paciﬁ  c. Cases described were isolated, 
rarely fatal, and involved infection 
through the skin (7–10). The V. vulniﬁ  -
cus infections we report may be related 
to the emergence of a new clone or to 
changes in the climate or environmen-
tal conditions. New Caledonia experi-
enced unusual weather conditions dur-
ing the ﬁ  rst half of 2008 (heavy rains 
and exceptionally high temperatures). 
These speciﬁ  c conditions may have fa-
vored higher sea surface temperatures, 
lower salinity, increased turbidity, and 
subsequent multiplication of V. vulniﬁ  -
cus in seawater. 
A range of projects were imple-
mented to train practitioners to recog-
nize potential V. vulniﬁ  cus infections. 
Local health authorities issued crite-
ria for deﬁ  ning suspected cases of V. 
vulniﬁ  cus infection and recommenda-
tions for early medical care of patients 
with clinical symptoms. Methods of 
detecting the bacterium in human and 
animal health laboratories were im-
proved, particularly by the systematic 
use of selective media in the event of 
suspected clinical V. vulniﬁ  cus infec-
tion and standardized reporting of V. 
vulniﬁ  cus isolation. Preventive mea-
sures, such as improving microbial 
surveillance and warning consum-
ers about risks associated with eating 
raw seafood, are essential to help re-
duce the risk for V. vulniﬁ  cus–induced 
illness. 
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etymologia etymologia
Vibrio vulniﬁ  cus
[vĭb’re-o vŭl-nĭf’ĭ-kəs]
From the Latin vibrio (to move) and vulniﬁ  cus (causing wounds). Vibrio vulniﬁ  cus is a virulent, gram-negative, 
comma-shaped, motile bacterium that belongs to the family Vibrionaceae. In 1976, researchers at the Centers 
for Disease Control  identiﬁ  ed it as a Vibrio sp. and possible emerging pathogen. Because of its association with 
blistering skin infections, the bacterium was named Vibrio vulniﬁ  cus in 1979.
Source:  Farmer JJ III. Vibrio (“Beneckea”) vulniﬁ  cus, the bacterium associated with sepsis, septicaemia and the sea. Lancet. 
1979;2:903; Hollis DG, Weaver RE, Baker CN, Thornsberry C. Halophilic Vibrio species isolated from blood cultures. J Clin 
Microbiol. 1976;3:425–31; Todar K. Todar’s online textbook of bacteriology. Vibrio vulniﬁ  cus. [cited 2010 Nov 24]. http://
textbookofbacteriology.net/v.vulniﬁ  cus.html; Dorland’s illustrated medical dictionary. 31st ed. Philadelphia: Saunders Elsevier; 
2007. 